BLADDER SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED

BLADDER SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED was reported 35 times

These drug classes are most commonly taken by patients reporting BLADDER SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED:

# Drug Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 4
1 Corticosteroid [EPC] 3
2 Integrin Receptor Antagonist [EPC] 3
3 Thalidomide Analog [EPC] 3
4 Alkylating Drug [EPC] 2
5 CD20-directed Cytolytic Antibody [EPC] 2
6 Calcineurin Inhibitor Immunosuppressant [EPC] 2
7 Insulin Analog [EPC] 2
8 Interleukin-12 Antagonist [EPC] 2
9 Interleukin-23 Antagonist [EPC] 2
10 Kinase Inhibitor [EPC] 2
11 Platelet Aggregation Inhibitor [EPC] 2
12 Platinum-based Drug [EPC] 2
13 Provitamin D2 Compound [EPC] 2
14 Sulfonylurea [EPC] 2
15 5-alpha Reductase Inhibitor [EPC] 1
16 Angiotensin 2 Receptor Blocker [EPC] 1
17 Atypical Antipsychotic [EPC] 1
18 BCL-2 Inhibitor [EPC] 1
19 Cholinergic Muscarinic Antagonist [EPC] 1
20 Complement Inhibitor [EPC] 1
21 Dietary Cholesterol Absorption Inhibitor [EPC] 1
22 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
23 Fluoroquinolone Antibacterial [EPC] 1
24 Folate Analog Metabolic Inhibitor [EPC] 1
25 HMG-CoA Reductase Inhibitor [EPC] 1
26 Insulin [EPC] 1
27 Interferon beta [EPC] 1
28 Interleukin-17A Antagonist [EPC] 1
29 Leukocyte Growth Factor [EPC] 1
30 Loop Diuretic [EPC] 1
31 Microtubule Inhibitor [EPC] 1
32 Osmotic Laxative [EPC] 1
33 PCSK9 Inhibitor [EPC] 1
34 Potassium Channel Blocker [EPC] 1
35 Potassium Salt [EPC] 1
36 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
37 Proton Pump Inhibitor [EPC] 1
38 Purine Antimetabolite [EPC] 1
39 Serotonin-3 Receptor Antagonist [EPC] 1
40 Sulfonamide Antimicrobial [EPC] 1
41 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
42 Vitamin B12 [EPC] 1
43 Vitamin C [EPC] 1
44 Vitamin D [EPC] 1
45 Xanthine Oxidase Inhibitor [EPC] 1
46 alpha-Glucosidase Inhibitor [EPC] 1
47 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1
48 mTOR Inhibitor Immunosuppressant [EPC] 1